Amgen Inc. (AMGN) 의 후행 P/E는 24.5, 선행 P/E 15.7. 후행 이익수익률은 4.07%, 선행 이익수익률 6.39%. PEG 0.28 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $71.91.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 64/100 4/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 14.2 | 1.11 | 3.66 | 4.76 | 2.74% |
| 2017 | 64.2 | -0.87 | 5.04 | 5.56 | 2.65% |
| 2018 | 15.3 | 0.04 | 10.29 | 5.42 | 2.73% |
| 2019 | 18.6 | 9.08 | 15.08 | 6.24 | 2.41% |
| 2020 | 18.5 | -4.29 | 14.32 | 5.30 | 2.79% |
| 2021 | 21.8 | -1.31 | 19.14 | 4.94 | 3.13% |
| 2022 | 21.6 | 1.21 | 38.60 | 5.37 | 2.97% |
| 2023 | 22.9 | 7.35 | 24.73 | 5.47 | 2.96% |
| 2024 | 34.5 | -0.88 | 23.99 | 4.22 | 3.43% |
| 2025 | 22.8 | 0.26 | 20.34 | 4.79 | 2.91% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $10.24 | $22.99B | $7.72B | 33.6% |
| 2017 | $2.69 | $22.85B | $1.98B | 8.7% |
| 2018 | $12.62 | $23.75B | $8.39B | 35.3% |
| 2019 | $12.88 | $23.36B | $7.84B | 33.6% |
| 2020 | $12.31 | $25.42B | $7.26B | 28.6% |
| 2021 | $10.28 | $25.98B | $5.89B | 22.7% |
| 2022 | $12.11 | $26.32B | $6.55B | 24.9% |
| 2023 | $12.49 | $28.19B | $6.72B | 23.8% |
| 2024 | $7.56 | $33.42B | $4.09B | 12.2% |
| 2025 | $14.23 | $36.74B | $7.71B | 21% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $22.41 | $20.70 – $23.57 | $37.84B | $37.46B – $38.67B | 21 |
| 2027 | $23.35 | $21.45 – $24.83 | $38.87B | $37.31B – $40.09B | 19 |
| 2028 | $24.22 | $18.95 – $32.36 | $39.77B | $39.77B – $39.77B | 10 |
| 2029 | $25.50 | $24.60 – $26.91 | $41.4B | $40.28B – $43.17B | 4 |
| 2030 | $27.55 | $26.58 – $29.08 | $42.75B | $41.59B – $44.58B | 4 |
